Heart Failure and Open-Heart Surgery

Ohio State First in Central Ohio to Use Novel Heart Failure Therapy

DAIC

FEBRUARY 26, 2024

milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.

Heart Failure

Heart Failure Open-Heart Surgery Hospital Outcomes

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

FEBRUARY 21, 2024

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. director of Interventional and Structural Heart Research at Henry Ford Hospital.

Heart Failure

Heart Failure Open-Heart Surgery Tricuspid Heart Disease

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

FEBRUARY 18, 2025

Traditionally, cardiothoracic surgeons have repaired or replaced the tricuspid valve during open-heart surgery and only when absolutely necessary; such surgeries are complex and risky. Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery.

Tricuspid

Tricuspid Open-Heart Surgery Quality of Life Anatomy

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Right ventricular myocardial edema leading to severe heart failure after open heart surgery – possible effect of high-dose corticosteroid therapy

Journal of Cardiothoracic Surgery

APRIL 4, 2024

Cardiopulmonary bypass induces a systemic inflammatory response and alterations in fluid homeostasis, resulting in generalized tissue edema. Additionally, ischemia-reperfusion injury following cardioplegic arr.

Open-Heart Surgery

Open-Heart Surgery Heart Failure Ischemia

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Conquering CHD

JANUARY 17, 2025

Zane had three open heart surgeries before he turned 3. Zeke and Zane were both diagnosed with hypoplastic left heart syndrome (HLHS) before birth. As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. And surprisingly, he had a more routine care journey than his brother, Zeke.

Heart Transplant

Heart Transplant Transplant Open-Heart Surgery Nursing

Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

DAIC

FEBRUARY 20, 2024

Many patients with symptoms of mitral regurgitation are not candidates for open heart surgery due to their advanced age or competing comorbidities, nor are they candidates for the only alternative, the MitraClip device. It is one of only two New Jersey hospitals offering the trial to patients.

Heart Valves

Heart Valves Bicuspid/Mitral Academic Chest Pain

Case Report: Successful retrieval of a migrated left atrial appendage occluder through the synergistic use of a guidewire and a gooseneck snare

Frontiers in Cardiovascular Medicine

JUNE 4, 2024

If the LAAO migrates into the left atrium or ventricle, it can lead to acute heart failure or even death in a person, necessitating urgent surgical intervention. Left atrial appendage occluder (LAAO) dislodgement with embolization is a rare occurrence.

Open-Heart Surgery

Open-Heart Surgery Embolism Article Innovation

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

APRIL 2, 2024

Sorajja added, "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."

Tricuspid

Tricuspid Heart Valves Quality of Life Open-Heart Surgery

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

JUNE 3, 2024

Without proper treatment, severe Mitral Regurgitation can cause major heart problems or even lead to heart failure. Limited treatment options are available for many patients at high surgical risk, TSMVR solutions offer a less invasive alternative to traditional open-heart surgery.

Bicuspid/Mitral

Bicuspid/Mitral Technology Open-Heart Surgery Innovation

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

Delivered through a vein in the leg, TriClip's TEER technology works by clipping together a portion of the leaflets – or flaps of tissue – to repair the tricuspid valve and help blood flow in the right direction without the need for open-heart surgery.

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Owing to high mortality risk, access to open heart surgery is severely restricted and is not considered an option for most patients with TR.

Tricuspid

Tricuspid Pacemaker Heart Valves Open-Heart Surgery

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

DAIC

DECEMBER 26, 2023

The potential to detect aortic stenosis through our IH technology is an exciting development that brings us a step closer to achieving the MindMics purpose to one day eliminate heart failure as the leading cause of death globally (similar to what glucose monitoring has done to transform diabetes)." "We

Stenosis

Stenosis Technology Aortic Aortic valve

People With Tricuspid Valve Disease Have New Treatment Options

DAIC

FEBRUARY 18, 2025

Traditionally, cardiothoracic surgeons have repaired or replaced the tricuspid valve during open-heart surgery and only when absolutely necessary; such surgeries are complex and risky. Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery.

Tricuspid

Tricuspid Open-Heart Surgery Quality of Life Anatomy

Cardiovascular Update

Ohio State First in Central Ohio to Use Novel Heart Failure Therapy

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

New Treatment Options Available for Patients with Tricuspid Valve Disease

Webinars

Right ventricular myocardial edema leading to severe heart failure after open heart surgery – possible effect of high-dose corticosteroid therapy

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Hackensack Meridian Jersey Shore University Medical Center Providing State-of-the-Art Medtronic APOLLO Clinical Trial Treating Heart Valve Disease

Case Report: Successful retrieval of a migrated left atrial appendage occluder through the synergistic use of a guidewire and a gooseneck snare

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

People With Tricuspid Valve Disease Have New Treatment Options

Stay Connected